Virus Antibody Testing Kalamazoo Mi
Lab Reagents
Human IgG antibody Laboratories manufactures the virus antibody testing kalamazoo mi reagents distributed by Genprice. The Virus Antibody Testing Kalamazoo Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Virus products are available in stock. Specificity: Virus Category: Antibody Group: Testing Kalamazoo
MI-136 |
|||
B6166-10 | ApexBio | 10 mg | EUR 373 |
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy. |
MI-136 |
|||
B6166-25 | ApexBio | 25 mg | EUR 757 |
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy. |
MI-136 |
|||
B6166-5 | ApexBio | 5 mg | EUR 232 |
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy. |
MI-2 |
|||
A3602-10 | ApexBio | 10 mg | EUR 282 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-200 | ApexBio | 200 mg | EUR 1558 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-5 | ApexBio | 5 mg | EUR 212 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 415 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-50 | ApexBio | 50 mg | EUR 630 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-3 |
|||
A3603-10 | ApexBio | 10 mg | EUR 400 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-100 | ApexBio | 100 mg | EUR 1553 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-5 | ApexBio | 5 mg | EUR 267 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 309 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-50 | ApexBio | 50 mg | EUR 1218 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-192 |
|||
C5851-10 | ApexBio | 10 mg | EUR 440 |
Description: MI-192 is a histone deacetylases (HDACs) inhibitor that preferentially inhibits HDAC2 and HDAC3 with IC50 values of 30 nM and 16 nM, respectively [1]. Histone acetylation is the most commonly employed mechanism utilized by transcription factors to activate gene expression. |
MI-192 |
|||
C5851-5 | ApexBio | 5 mg | EUR 270 |
Description: MI-192 is a histone deacetylases (HDACs) inhibitor that preferentially inhibits HDAC2 and HDAC3 with IC50 values of 30 nM and 16 nM, respectively [1]. Histone acetylation is the most commonly employed mechanism utilized by transcription factors to activate gene expression. |
Human Mi-2 Antibody (Anti-Mi-2) ELISA Kit |
|||
abx052588-96tests | Abbexa | 96 tests | EUR 668 |
MI-nc (hydrochloride) |
|||
B2816-1 | Biovision | EUR 142 |